442
Views
18
CrossRef citations to date
0
Altmetric
Brief Reports

Validation of Biomarkers of CVD Risk from Dried Blood Spots in Community-Based Research: Methodologies and Study-Specific Serum Equivalencies

, , , , , , , & show all

References

  • Bland, J. M., and D. G. Altman. 1999. Measuring agreement in method comparison studies. Statistical Methods in Medical Research 8 (2):135–60. doi:10.1191/096228099673819272.
  • Boekholdt, S. M., C. E. Hack, M. S. Sandhu, R. Luben, S. A. Bingham, N. J. Wareham, R. J. Peters, et al. 2006. C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: The EPIC-Norfolk prospective population study 1993–2003. Atherosclerosis 187 (2):415–22. doi:10.1016/j.atherosclerosis.2005.09.023.
  • Bray, J. W., E. Kelly, L. B. Hammer, D. M. Almeida, J. W. Dearing, R. Berkowitz King, and O. M. Buxton. 2013. An integrative, multilevel, and transdisciplinary research approach to challenges of work, family, and health. Research Triangle Park, NC: RTI Press.
  • Brindle, E., M. Fujita, J. Shofer, and K. A. O’Connor. 2010. Serum, plasma, and dried blood spot high-sensitivity C-reactive protein enzyme immunoassay for population research. Journal of Immunological Methods 362:112–20. doi:10.1016/j.jim.2010.09.014.
  • Buxton, O. M., K. Hopcia, G. Sembajwe, J. H. Porter, J. T. Dennerlein, C. Kenwood, A. M. Stoddard, D. Hashimoto, and G. Sorensen. 2012. Relationship of sleep deficiency to perceived pain and functional limitations in hospital patient care workers. Journal of Occupational and Environmental Medicine 54 (7):851–58. doi:10.1097/JOM.0b013e31824e6913.
  • Buxton, O. M., L. C. Klein, J. Whinnery, S. Williams, and T. McDade. 2013. Biomarkers in work and family research. In New frontiers in work and family research, ed. J. G. Grzywacz and E. Demerouti, 170–90. East Sussex, UK: Psychology Press.
  • Chamoles, N. A., G. Niizawa, M. Blanco, D. Gaggioli, and C. Casentini. 2004. Glycogen storage disease type II: Enzymatic screening in dried blood spots on filter paper. Clinica Chimica Acta 347 (1–2):97–102. doi:10.1016/j.cccn.2004.04.009.
  • Crimmins, E., J. K. Kim, H. McCreath, J. Faul, D. Weir, and T. Seeman. 2014. Validation of blood-based assays using dried blood spots for use in large population studies. Biodemography and Social Biology 60 (1):38–48. doi:10.1080/19485565.2014.901885.
  • De Jesus, V. R., X. K. Zhang, J. Keutzer, O. A. Bodamer, A. Muhl, J. J. Orsini, M. Caggana, R. F. Vogt, and W. H. Hannon. 2009. Development and evaluation of quality control dried blood spot materials in newborn screening for lysosomal storage disorders. Clinical Chemistry 55 (1):158–64. doi:10.1373/clinchem.2008.111864.
  • Gordon, T., W. P. Castelli, M. C. Hjortland, W. B. Kannel, and T. R. Dawber. 1977. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. American Journal of Medicine 62 (5):707–14. doi:10.1016/0002-9343(77)90874-9.
  • Grundy, S. M., J. I. Cleeman, C. N. Merz, H. B. Brewer Jr., L. T. Clark, D. B. Hunninghake, R. C. Pasternak, S. C. Smith Jr., and N. J. Stone. 2004. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Arteriosclerosis, Thrombosis, and Vascular Biology 24 (8):e149–61. doi:10.1161/01.ATV.0000133317.49796.0E.
  • Kannel, W. B., W. P. Castelli, T. Gordon, and P. M. McNamara. 1971. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Annals of Internal Medicine 74 (1):1–12. doi:10.7326/0003-4819-74-1-1.
  • King, R. B., G. T. Karuntzos, L. M. Casper, P. Moen, K. D. Davis, L. Berkman, M. Durham, and E. E. Kossek. 2013. Work-family balance issues and work-leave policies. In Handbook of occpational health and wellness, ed. R. J. Gatchel and I. Z. Schultz, 323–40. New York: Springer.
  • Lacher, D. A., L. E. Berman, T. C. Chen, and K. S. Porter. 2013. Comparison of dried blood spot to venous methods for hemoglobin A1c, glucose, total cholesterol, high-density lipoprotein cholesterol, and C-reactive protein. Clinica Chimica Acta 422:54–58. doi:10.1016/j.cca.2013.03.032.
  • McDade, T. W. 2013. Development and validation of assay protocols for use with dried blood spot samples. American Journal of Human Biology 26 (1):1–9. doi:10.1002/ajhb.22463.
  • McDade, T. W., J. Burhop, and J. Dohnal. 2004. High-sensitivity enzyme immunoassay for C-reactive protein in dried blood spots. Clinical Chemistry 50 (3):652–54. doi:10.1373/clinchem.2003.029488.
  • McDade, T. W., S. Williams, and J. J. Snodgrass. 2007. What a drop can do: Dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography 44 (4):899–925. doi:10.1353/dem.2007.0038.
  • Ostler, M. W., J. H. Porter, and O. M. Buxton. 2014. Dried blood spot collection of health biomarkers to maximize participation in population studies. Journal of Visualized Experiments 28 (83):e50973.
  • Pai, J. K., T. Pischon, J. Ma, J. E. Manson, S. E. Hankinson, K. Joshipura, G. C. Curhan, et al. 2004. Inflammatory markers and the risk of coronary heart disease in men and women. New England Journal of Medicine 351 (25):2599–610. doi:10.1056/NEJMoa040967.
  • Ridker, P. M. 2003. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: Rationale and design of the JUPITER trial. Circulation 108 (19):2292–97. doi:10.1161/01.CIR.0000100688.17280.E6.
  • Sorensen, G., A. M. Stoddard, S. Stoffel, O. M. Buxton, G. Sembajwe, D. Hashimoto, J. T. Dennerlein, and K. Hopcia. 2011. The role of the work context in multiple wellness outcomes for hospital patient care workers. Journal of Occupational and Environmental Medicine 53 (8):899–910. doi:10.1097/JOM.0b013e318226a74a.
  • Therrell, B. L., W. H. Hannon, K. A. Pass, F. Lorey, C. Brokopp, J. Eckman, M. Glass, et al. 1996. Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: Statement of the council of regional networks for genetic services. Biochemical and Molecular Medicine 57 (2):116–24. doi:10.1006/bmme.1996.0017.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.